All News
Filter News
Found 808,606 articles
-
GlaxoSmithKline Selects Veeva Systems, Inc. As Global Multichannel CRM Partner
3/17/2015
-
BioInvent Announces Plan To Initiate Clinical Development Of TB-403 In Pediatric Cancer Together With ThromboGenics Ltd.
3/17/2015
-
Boston Therapeutics, Inc. And Advance Pharmaceutical Expand Sugardown Licensing Agreement To Japan; Increases Number Of Asian Countries To 16
3/17/2015
-
Johnson & Johnson Announces Strategic Investment Alliance To Combat Dementia Globally
3/17/2015
-
Tokai Pharmaceuticals Announces Expansion To Collaboration With QIAGEN N.V. On The Development Of An AR-V7 Companion Diagnostic
3/17/2015
-
VALNEVA Announces Signing Of An Exclusive License Agreement On EB66 Cell Line For Human And Veterinary Vaccines In China
3/17/2015
-
Genedata AG Partners With Bayer Pharma AG On Innovative Workflow Platform For High-Throughput Cell Line Development
3/17/2015
-
Taconic Biosciences Strengthens Japanese Distribution And Breeding Partnerships
3/17/2015
-
Cartagenia n.v. Partners With N-Of-One To Provide Pathology Laboratories And Cancer Centers Access To Clinical Interpretation Services
3/17/2015
-
GliaCure Receives $1 Million Grant For Phase 1b Alzheimer's Clinical Trial
3/17/2015
-
Alzheimer’s Research UK To Back $100m New Dementia Discovery Fund
3/17/2015
-
Duchesnay inc. Release: Expansion Overseas – Diclectin For Nausea And Vomiting Of Pregnancy (NVP) Now Available In Israel
3/17/2015
-
Daxor Corporation Receives Notification Of Patent Approval And Issues An Update On Its Stock Buyback Program
3/17/2015
-
NanoTherapies Closes Final Round Of Financing For Completion Of New Advanced Development And Manufacturing Facility
3/17/2015
-
New Oncology Closes Financing Round To Promote Genetic Testing From Blood
3/17/2015
-
Advanced Catheter Therapies Completes Series B Funding With Toray Industries, Inc.
3/17/2015
-
Valeant Announces Offering Of $1.45 Billion Of Common Shares
3/17/2015
-
Valeant Prices Offering Of $1.45 Billion Of Common Shares
3/17/2015
-
Heat Biologics Announces Closing Of Public Offering Of Common Stock And Full Exercise Of The Underwriters' Over-Allotment Option
3/17/2015
-
Eagle Pharmaceuticals Announces Pricing Of Public Offering Of Common Stock
3/17/2015